Cargando…
Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484807/ https://www.ncbi.nlm.nih.gov/pubmed/36107794 http://dx.doi.org/10.15585/mmwr.mm7137e1 |
| _version_ | 1784791951696986112 |
|---|---|
| author | O’Laughlin, Kevin Tobolowsky, Farrell A. Elmor, Riad Overton, Rahsaan O’Connor, Siobhán M. Damon, Inger K. Petersen, Brett W. Rao, Agam K. Chatham-Stephens, Kevin Yu, Patricia Yu, Yon Ahmadi, Sarah Avery, Rachel Bean, Kathryn Beavers, Leah Belanger Giguere, Kim Brownlee, Joi Campbell, Catherine Cheng, Maggie Clinton, Rachel Coleman, Taylor Davis, Monique S. Dubreus, Marie Henry, Meryl Lozoya, Sujeith B. Morgan, Jahnae Muhammad, Kalimah Parker, Corinne M. Peters, Nigel Rybak, Ellery Schwenk, Andrew van Loben Sels, Jessica Veillard,, Max |
| author_facet | O’Laughlin, Kevin Tobolowsky, Farrell A. Elmor, Riad Overton, Rahsaan O’Connor, Siobhán M. Damon, Inger K. Petersen, Brett W. Rao, Agam K. Chatham-Stephens, Kevin Yu, Patricia Yu, Yon Ahmadi, Sarah Avery, Rachel Bean, Kathryn Beavers, Leah Belanger Giguere, Kim Brownlee, Joi Campbell, Catherine Cheng, Maggie Clinton, Rachel Coleman, Taylor Davis, Monique S. Dubreus, Marie Henry, Meryl Lozoya, Sujeith B. Morgan, Jahnae Muhammad, Kalimah Parker, Corinne M. Peters, Nigel Rybak, Ellery Schwenk, Andrew van Loben Sels, Jessica Veillard,, Max |
| author_sort | O’Laughlin, Kevin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9484807 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94848072022-09-22 Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 O’Laughlin, Kevin Tobolowsky, Farrell A. Elmor, Riad Overton, Rahsaan O’Connor, Siobhán M. Damon, Inger K. Petersen, Brett W. Rao, Agam K. Chatham-Stephens, Kevin Yu, Patricia Yu, Yon Ahmadi, Sarah Avery, Rachel Bean, Kathryn Beavers, Leah Belanger Giguere, Kim Brownlee, Joi Campbell, Catherine Cheng, Maggie Clinton, Rachel Coleman, Taylor Davis, Monique S. Dubreus, Marie Henry, Meryl Lozoya, Sujeith B. Morgan, Jahnae Muhammad, Kalimah Parker, Corinne M. Peters, Nigel Rybak, Ellery Schwenk, Andrew van Loben Sels, Jessica Veillard,, Max MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-09-16 /pmc/articles/PMC9484807/ /pubmed/36107794 http://dx.doi.org/10.15585/mmwr.mm7137e1 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report O’Laughlin, Kevin Tobolowsky, Farrell A. Elmor, Riad Overton, Rahsaan O’Connor, Siobhán M. Damon, Inger K. Petersen, Brett W. Rao, Agam K. Chatham-Stephens, Kevin Yu, Patricia Yu, Yon Ahmadi, Sarah Avery, Rachel Bean, Kathryn Beavers, Leah Belanger Giguere, Kim Brownlee, Joi Campbell, Catherine Cheng, Maggie Clinton, Rachel Coleman, Taylor Davis, Monique S. Dubreus, Marie Henry, Meryl Lozoya, Sujeith B. Morgan, Jahnae Muhammad, Kalimah Parker, Corinne M. Peters, Nigel Rybak, Ellery Schwenk, Andrew van Loben Sels, Jessica Veillard,, Max Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 |
| title | Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 |
| title_full | Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 |
| title_fullStr | Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 |
| title_full_unstemmed | Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 |
| title_short | Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 |
| title_sort | clinical use of tecovirimat (tpoxx) for treatment of monkeypox under an investigational new drug protocol — united states, may–august 2022 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484807/ https://www.ncbi.nlm.nih.gov/pubmed/36107794 http://dx.doi.org/10.15585/mmwr.mm7137e1 |
| work_keys_str_mv | AT olaughlinkevin clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT tobolowskyfarrella clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT elmorriad clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT overtonrahsaan clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT oconnorsiobhanm clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT damoningerk clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT petersenbrettw clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT raoagamk clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT chathamstephenskevin clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT yupatricia clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT yuyon clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT ahmadisarah clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT averyrachel clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT beankathryn clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT beaversleah clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT belangergiguerekim clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT brownleejoi clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT campbellcatherine clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT chengmaggie clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT clintonrachel clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT colemantaylor clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT davismoniques clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT dubreusmarie clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT henrymeryl clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT lozoyasujeithb clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT morganjahnae clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT muhammadkalimah clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT parkercorinnem clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT petersnigel clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT rybakellery clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT schwenkandrew clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT vanlobenselsjessica clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 AT veillardmax clinicaluseoftecovirimattpoxxfortreatmentofmonkeypoxunderaninvestigationalnewdrugprotocolunitedstatesmayaugust2022 |